The endocannabinoid system and its therapeutic exploitation - PubMed (original) (raw)
Review
doi: 10.1038/nrd1495.
Affiliations
- PMID: 15340387
- DOI: 10.1038/nrd1495
Review
The endocannabinoid system and its therapeutic exploitation
Vincenzo Di Marzo et al. Nat Rev Drug Discov. 2004 Sep.
Abstract
The term 'endocannabinoid' - originally coined in the mid-1990s after the discovery of membrane receptors for the psychoactive principle in Cannabis, Delta9-tetrahydrocannabinol and their endogenous ligands - now indicates a whole signalling system that comprises cannabinoid receptors, endogenous ligands and enzymes for ligand biosynthesis and inactivation. This system seems to be involved in an ever-increasing number of pathological conditions. With novel products already being aimed at the pharmaceutical market little more than a decade since the discovery of cannabinoid receptors, the endocannabinoid system seems to hold even more promise for the future development of therapeutic drugs. We explore the conditions under which the potential of targeting the endocannabinoid system might be realized in the years to come.
Similar articles
- The endocannabinoid system: a drug discovery perspective.
Piomelli D. Piomelli D. Curr Opin Investig Drugs. 2005 Jul;6(7):672-9. Curr Opin Investig Drugs. 2005. PMID: 16044662 Review. - The endocannabinoid signalling system: biochemical aspects.
Bisogno T, Ligresti A, Di Marzo V. Bisogno T, et al. Pharmacol Biochem Behav. 2005 Jun;81(2):224-38. doi: 10.1016/j.pbb.2005.01.027. Pharmacol Biochem Behav. 2005. PMID: 15935454 Review. - The future of cannabinoids as analgesic agents: a pharmacologic, pharmacokinetic, and pharmacodynamic overview.
McCarberg BH, Barkin RL. McCarberg BH, et al. Am J Ther. 2007 Sep-Oct;14(5):475-83. doi: 10.1097/MJT.0b013e3180a5e581. Am J Ther. 2007. PMID: 17890938 Review. - Cannabinoid analgesia as a potential new therapeutic option in the treatment of chronic pain.
Burns TL, Ineck JR. Burns TL, et al. Ann Pharmacother. 2006 Feb;40(2):251-60. doi: 10.1345/aph.1G217. Epub 2006 Jan 31. Ann Pharmacother. 2006. PMID: 16449552 Review. - [Functional organization ant therapeutic potential of the endogenous cannabinoid system].
Churiukanov MV, Churiukanov VV. Churiukanov MV, et al. Eksp Klin Farmakol. 2004 Mar-Apr;67(2):70-8. Eksp Klin Farmakol. 2004. PMID: 15188768 Review. Russian. No abstract available.
Cited by
- Cannabinoid type-2 receptors: An emerging target for regulating schizophrenia-relevant brain circuits.
Ferranti AS, Foster DJ. Ferranti AS, et al. Front Neurosci. 2022 Aug 11;16:925792. doi: 10.3389/fnins.2022.925792. eCollection 2022. Front Neurosci. 2022. PMID: 36033626 Free PMC article. Review. - Getting to the core of addiction: Hooking CB2 receptor into drug abuse?
Morales M, Bonci A. Morales M, et al. Nat Med. 2012 Apr 5;18(4):504-5. doi: 10.1038/nm.2722. Nat Med. 2012. PMID: 22481411 Free PMC article. No abstract available. - Modulating the endocannabinoid system in human health and disease--successes and failures.
Pacher P, Kunos G. Pacher P, et al. FEBS J. 2013 May;280(9):1918-43. doi: 10.1111/febs.12260. Epub 2013 Apr 22. FEBS J. 2013. PMID: 23551849 Free PMC article. Review. - The endocannabinoid system in the physiology and pathophysiology of the gastrointestinal tract.
Massa F, Storr M, Lutz B. Massa F, et al. J Mol Med (Berl). 2005 Dec;83(12):944-54. doi: 10.1007/s00109-005-0698-5. Epub 2005 Aug 26. J Mol Med (Berl). 2005. PMID: 16133420 Review. - Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury.
Bátkai S, Osei-Hyiaman D, Pan H, El-Assal O, Rajesh M, Mukhopadhyay P, Hong F, Harvey-White J, Jafri A, Haskó G, Huffman JW, Gao B, Kunos G, Pacher P. Bátkai S, et al. FASEB J. 2007 Jun;21(8):1788-800. doi: 10.1096/fj.06-7451com. Epub 2007 Feb 27. FASEB J. 2007. PMID: 17327359 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources